Webinar: Alemtuzumab Info

PODCAST

PART I: Lecture

PART II: Discussion

Calendar of Events

September 2016
S M T W T F S
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 1

Archives




Archive Articles - 2010 PDF Print E-mail
Written by IOMSN Administrator   

 

 

DATE POSTED T I T L E
September 22, 2010 New Oral Medication for Multiple Sclerosis! Novartis gains FDA approval for Gilenya, a novel first-line MS treatment
PDF: 132 KB

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IOMSN Endorsement Policy




USA | CANADA | INT'L


Regional Meetings - 2016


Nurses' Experiences







Reference Materials Links